Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases affecting millions worldwide.
Inflammation is the body’s frontline defense against infection and injury, but when it doesn’t switch off properly, it can drive serious health conditions such as arthritis, heart disease, and diabetes. Until now, scientists didn’t fully understand how the body decides to stop the immune “fight” response and start healing.
Published in Nature Communications, the study reveals that tiny fat-derived molecules called epoxy-oxylipins act as natural brakes on the immune system. These molecules prevent the overgrowth of certain immune cells, known as intermediate monocytes, that can cause chronic inflammation—linked to tissue damage, illness and disease progression.
For the study, healthy human volunteers were given a tiny injection of UV-killed E. coli bacteria into the forearm, which triggered a short-lived inflammatory reaction—pain, redness, heat and swelling—similar to what happens after an infection or injury.
Volunteers were split into two groups: prophylactic arm and therapeutic arm.
At different times, the volunteer groups were given a drug called GSK2256294, which blocks an enzyme known as soluble epoxide hydrolase (sEH), which naturally breaks down epoxy-oxylipins.
- Prophylactic arm: Participants received the drug two hours before inflammation began, to see if boosting epoxy-oxylipins early could prevent harmful immune changes. In this group there were 24 volunteers—12 were treated, 12 untreated (placebo).
- Therapeutic arm: Participants received the drug four hours after inflammation started, mimicking real-world treatment once symptoms appear. In this group there were 24 volunteers—12 were treated, 12 untreated (placebo).
Both approaches showed that blocking the enzyme sEH with GSK2256294 raised epoxy-oxylipin levels, accelerated pain resolution, and sharply reduced levels of intermediate monocytes in blood and tissue—the immune cells linked to chronic inflammation and disease. Interestingly, the drug did not significantly alter external symptoms, such as redness and swelling.
Further tests revealed that one epoxy-oxylipin, 12,13-EpOME, works by shutting down a protein signal called p38 MAPK, which drives monocyte transformation. This was confirmed in lab experiments and in volunteers given a p38-blocking drug.
First author Dr. Olivia Bracken (UCL Department of Aging, Rheumatology and Regenerative Medicine) said, “Our findings reveal a natural pathway that limits harmful immune cell expansion and helps calm inflammation more quickly.
“Targeting this mechanism could lead to safer treatments that restore immune balance without suppressing overall immunity.
“With chronic inflammation ranked as a major global health threat, this discovery opens a promising avenue for new therapies.”
Corresponding author Professor Derek Gilroy (UCL Division of Medicine) said, “This is the first study to map epoxy-oxylipin activity in humans during inflammation.
“By boosting these protective fat molecules, we could design safer treatments for diseases driven by chronic inflammation.”
He added, “This was an entirely human-based study with direct relevance to autoimmune diseases, as we used a drug already suitable for human use—one that could be repurposed to treat flares in chronic inflammatory conditions, an area currently bereft of effective therapies.”
Why epoxy-oxylipins?
Scientists chose to study epoxy-oxylipins because these fat-derived molecules were known from animal research to reduce inflammation and pain, but their role in humans remained unknown. Unlike well-studied inflammatory mediators, such as histamine and cytokines, epoxy-oxylipins are part of an underexplored pathway that scientists believed could naturally calm the immune system.
Next steps
The discovery opens the door to clinical trials exploring sEH inhibitors as potential therapies for conditions like rheumatoid arthritis and cardiovascular disease.
Dr. Bracken said, “For instance, rheumatoid arthritis is a condition in which the immune system attacks the cells that line your joints. sEH inhibitors could be trialed alongside existing medications to investigate if they can help prevent or slow down joint damage incurred by the condition.”
Dr. Caroline Aylott, Head of Research Delivery at Arthritis UK, said, “The pain of arthritis can affect how we move, think, sleep and feel, along with our ability to spend time with loved ones. Pain is incredibly complex and is affected by many different factors. We also know that everybody’s pain is different.
“That is why it is important that we invest in research like this that helps us understand what causes and influences people’s experience of pain.
“We are excited to see the results of this study which has found a natural process that could stop inflammation and pain. We hope in the future that this will lead to new pain management options for people with arthritis.”
Publication details
Epoxy-Oxylipins Direct Monocyte Fate in Inflammatory Resolution in Humans, Nature Communications (2026). DOI: 10.1038/s41467-025-67961-5
Journal information: Nature Communications
News
Researcher at Russian plague laboratory dies of ‘unknown’ infection
Russian authorities have imposed "anti-epidemic measures" after a laboratory worker at an institute in Siberia dedicated to studying the plague and other infectious diseases died of a mysterious illness. The researcher, a 28-year-old female [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
A Surprising Brain Signal Could Explain Why Eating Less Protein Extends Lifespan
A new paper suggests that limiting protein intake triggers a coordinated response throughout the body that may help explain how protein restriction affects healthy aging. Animals respond to protein restriction, or reduced protein in [...]
Back and shoulder surgery is often worse than useless
Millions of operations should be scrapped SIX IN TEN Britons have surgery at some point. So do lots of Americans, at a cost of perhaps $500bn a year, a third of all spending on [...]
Cocaine plays with mind, hijacks brain circuit, drives increasingly rigid and repetitive behavior
Researchers have found that cocaine hijacks brain circuit, which to drive increasingly rigid and repetitive behavior. The brain circuit that normally participates in selecting natural mouth and face movements, but which becomes disproportionately engaged [...]
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
The brain cancer glioblastoma is one of the most aggressive and treatment-resistant cancers known to medicine, carrying a median survival of just 12-15 months, even with the best available care. Now, researchers at the [...]
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol [...]
Too Much RNA Can Drain a Cell’s Energy, Scientists Discover
A virus may cripple a cell’s power supply simply by producing too much of a molecule the cell needs to survive. New research from the Texas A&M College of Veterinary Medicine and Biomedical Sciences [...]
West African scientists warn of weakening health systems and urge stronger outbreak detection
LOME, Togo (AP) — West African laboratory scientists called on governments Friday to strengthen capacity to detect disease outbreaks to avoid another major outbreak, saying health systems across the region are becoming weaker. Participants [...]
A Little-Known Protein Could Point to a New Way To Treat Alzheimer’s
A study suggests that increasing SORLA protein levels could help treat Alzheimer’s disease and other disorders involving tau protein. Increasing SORLA, a protein with a protective role in the brain, helped mice withstand damage [...]
Cancer’s Hidden Antioxidant Shield Helps It Escape the Immune System
Blocking an antioxidant protein that tumors use to suppress immune attacks improved cancer immunotherapy responses in mice. Cancer cells can release antioxidants that interfere with the immune cells trying to kill them. Researchers have [...]
Scientists Find a Berry Compound That Helps Muscle Cells Burn Fat
Pterostilbene, a compound found naturally in some foods, affects how skeletal muscles process fats by stabilizing a protein called PPARδ and increasing its signaling activity. Pterostilbene, a natural compound found in blueberries, grapes, and [...]
Two Hidden Forces Help Build the Human Brain Before Birth
Scientists have uncovered two surprising forces that help guide how the human brain forms before birth. Before birth, the human brain is shaped in large part by an unusual class of stem cells known [...]
Researchers Uncover a Hidden Trigger Behind Chronic Inflammation
The findings offer new insights that could help guide the development of future therapies. A protein called human resistin may help flip on one of the immune system’s most powerful inflammatory switches. Researchers at [...]
Scientists Have Uncovered Previously Hidden Microbial Activity on Human Skin
The most abundant microbes on your skin may not be the ones doing most of the work. Human skin supports vast communities of bacteria, fungi, and viruses that can influence its protective barrier, immune [...]
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
